EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial

K D Crew, G L Anderson, K B Arnold, A P Stieb, J N Amenta, N Collins, C W Law, S Pruthi, A Sandoval-Leon, D Bertoni, M T Grosse Perdekamp, S Colonna und 24 weitere

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107564 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von K D Crew und 35 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York, NY, USA. Electronic address: kd59@cumc.columbia.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Chemoprevention. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Women with atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS) have a significantly increased risk of breast cancer, which can be substantially reduced with antiestrogen therapy for chemoprevention. However, antiestrogen therapy for breast cancer risk reduction remains underutilized. Improving knowledge about breast cancer risk and chemoprevention among high-risk patients and their healthcare providers may enhance informed decision-making about this critical breast cancer risk reduction strategy. METHODS/DESIGN: We are conducting a cluster randomized controlled trial to evaluate the effectiveness and implementation of patient and provider decision support tools to improve informed choice about chemoprevention among women with AH or LCIS. We have cluster randomized 26 sites across the U.S. through the SWOG Cancer Research Network. A total of 415 patients and 200 healthcare providers are being recruited. They are assigned to standard educational materials alone or combined with the web-based decision support tools. Patient-reported and clinical outcomes are assessed at baseline, after a follow-up visit at 6 months, and yearly for 5 years. The primary outcome is chemoprevention informed choice after the follow-up visit. Secondary endpoints include other patient-reported outcomes, such as chemoprevention knowledge, decision conflict and regret, and self-reported chemoprevention usage. Barriers and facilitators to implementing decision support into clinic workflow are assessed through patient and provider interviews at baseline and mid-implementation. RESULTS/DISCUSSION: With this hybrid effectiveness/implementation study, we seek to evaluate if a multi-level intervention effectively promotes informed decision-making about chemoprevention and provide valuable insights on how the intervention is implemented in U.S. TRIAL REGISTRATION: NCT04496739.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsChemopreventionAdultFemaleHumansMiddle AgedDecision MakingDecision Support TechniquesEstrogen AntagonistsHealth Knowledge, Attitudes, PracticePatient Education as TopicPatient Reported Outcome MeasuresResearch DesignRisk Reduction BehaviorRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Breast cancer chemopreventionCluster randomized trialDecision support

Substanzen

Estrogen Antagonists

Autor:innen und Institutionen

  • Columbia University Irving Medical Center, New York, NY, USA. Electronic address: kd59@cumc.columbia.edu.
  • SWOG Statistics and Data Management Center, Seattle, WA, USA.
  • Columbia University Irving Medical Center, New York, NY, USA.
  • Mayo Clinic, Rochester, MN, United States of America.
  • Miami Cancer Institute at Baptist Health South Florida, Miami, FL, USA.
  • Good Samaritan Hospital Corvallis, Corvallis, OR (rshirley@samhealth.org), USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • NCI

Zitieren

APA

Crew, K. D., Anderson, G. L., Arnold, K. B., Stieb, A. P., Amenta, J. N., Collins, N., Law, C. W., Pruthi, S., Sandoval-Leon, A., Bertoni, D., Grosse Perdekamp, M. T., Colonna, S., Krisher, S., King, T., Yee, L. D., Ballinger, T. J., Braun-Inglis, C., Mangino, D., Wisinski, K. B., …, & Kukafka, R. (2024). Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107564

Vancouver

Crew KD, Anderson GL, Arnold KB, Stieb AP, Amenta JN, Collins N, et al. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107564

BibTeX
@article{Crew2024,
  author = {Crew, K D and Anderson, G L and Arnold, K B and Stieb, A P and Amenta, J N and Collins, N and Law, C W and Pruthi, S and Sandoval-Leon, A and Bertoni, D and Grosse Perdekamp, M T and Colonna, S and Krisher, S and King, T and Yee, L D and Ballinger, T J and Braun-Inglis, C and Mangino, D and Wisinski, K B and DeYoung, C A and Ross, M and Floyd, J and Kaster, A and Vander Walde, L and Saphner, T and Zarwan, C and Lo, S and Graham, C and Conlin, A and Yost, K and Agnese, D and Jernigan, C and Hershman, D L and Neuhouser, M L and Arun, B and Kukafka, R},
  title = {Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107564}
}
Kostenlos starten →